Source comparison
BPC-157 Help Ligament Tear Recovery: Research Comparison
Rat Achilles Tendon (2016, J Orthopaedic Research) Complete transection 10 µg/kg subcutaneous daily 14 days to structural recovery Untreated: 56+ days Profound effect in rodent model. No human equivalent trial exists Rat ACL Tear (2014, Med Sci Monit) Partial
This comparison does not assign a generated winner or score.
- Rat Achilles Tendon (2016, J Orthopaedic Research)
- Complete transection
- 10 µg/kg subcutaneous daily
- 14 days to structural recovery
- Untreated: 56+ days
- Profound effect in rodent model. No human equivalent trial exists
- Rat ACL Tear (2014, Med Sci Monit)
- Partial ligament tear
- 10 µg/kg intraperitoneal daily
- 21 days to tensile strength restoration
- Saline control: 42 days
- VEGF expression increased 68%. Mechanism confirmed, scaling uncertain
- In Vitro Fibroblast Study (2018, Molecules)
- Cultured human fibroblasts
- 1–10 µg/mL culture medium
- 72 hours to collagen upregulation
- Baseline: no change
- Human cells respond to BPC-157 in culture. Dosing translation unknown
- Anecdotal Case Reports (Athletic Community)
- Various soft tissue injuries
- 250–500 µg subcutaneous twice daily
- 4–8 weeks reported subjective improvement
- No control. Self-reported
- Placebo effect, spontaneous healing, or genuine peptide action indistinguishable
- The pattern: animal data is consistent and mechanistically sound. Human data is non-existent in formal trial structure. The gap is not a minor detail. It's the difference between a validated therapeutic and an experimental compound.